Literature DB >> 28388721

Safety and Patient Satisfaction of AbobotulinumtoxinA for Aesthetic Use: A Systematic Review.

Joel L Cohen1,2, Nicolo Scuderi3.   

Abstract

A systematic review of the published literature (from January 2000 to January 2016) to ascertain the safety of, and patient satisfaction with, the aesthetic use of abobotulinumtoxinA was conducted. In addition to the licensed indications, other special populations were considered for discussion. The potential impact of neutralizing antibodies and systemic toxicity were also addressed. A total of 364 papers were screened and 86 were found to be relevant to the population, intervention(s), and outcomes stipulated in the protocol. The safety and patient satisfaction data from these publications are discussed in this review.
© 2017 The American Society for Aesthetic Plastic Surgery, Inc.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28388721      PMCID： PMC5434490          DOI： 10.1093/asj/sjx010

Source DB:  PubMed          Journal:  Aesthet Surg J        ISSN： 1090-820X            Impact factor:   4.283


  83 in total

1.  Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety.

Authors:  Fredric Brandt; Neil Swanson; Leslie Baumann; Barbara Huber
Journal:  Dermatol Surg       Date:  2009-12       Impact factor: 3.398

2.  Recommendations for the best possible use of botulinum neurotoxin type a (Speywood units) for aesthetic applications.

Authors:  Berthold Rzany; Alina A M Fratila; Tanja C Fischer; Said Hilton; Tatjana Pavicic; Alexander Rothhaar; Gerhard Sattler; Boris Sommer; Andy Pickett
Journal:  J Drugs Dermatol       Date:  2013-01       Impact factor: 2.114

Review 3.  Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction.

Authors:  Koenraad De Boulle; Steven Fagien; Boris Sommer; Richard Glogau
Journal:  Clin Interv Aging       Date:  2010-04-26       Impact factor: 4.458

4.  Botulinum neurotoxin type A-ABO (Dysport): clinical indications and practice guide.

Authors:  Alan Matarasso; David Shafer
Journal:  Aesthet Surg J       Date:  2009-11       Impact factor: 4.283

5.  An analysis of the long-term safety data of repeat administrations of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.

Authors:  Joel L Cohen; Joel Schlessinger; Sue Ellen Cox; Xiaoming Lin
Journal:  Aesthet Surg J       Date:  2009-11       Impact factor: 4.283

6.  Medical rhinoplasty with hyaluronic acid and botulinum toxin A: a very simple and quite effective technique.

Authors:  Alessio Redaelli
Journal:  J Cosmet Dermatol       Date:  2008-09       Impact factor: 2.696

7.  Long-term safety of repeated administrations of a new formulation of botulinum toxin type A in the treatment of glabellar lines: interim analysis from an open-label extension study.

Authors:  Gary D Monheit; Joel L Cohen
Journal:  J Am Acad Dermatol       Date:  2009-07-03       Impact factor: 11.527

8.  Development and psychometric evaluation of the FACE-Q satisfaction with appearance scale: a new patient-reported outcome instrument for facial aesthetics patients.

Authors:  Andrea L Pusic; Anne F Klassen; Amie M Scott; Stefan J Cano
Journal:  Clin Plast Surg       Date:  2013-04       Impact factor: 2.017

9.  Botulinum toxin to improve results in cleft lip repair: a double-blinded, randomized, vehicle-controlled clinical trial.

Authors:  Chun-Shin Chang; Christopher Glenn Wallace; Yen-Chang Hsiao; Chee-Jen Chang; Philip Kuo-Ting Chen
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

Review 10.  Nonallergic Eyelid Edema After Botulinum Toxin Type A Injection: Case Report and Review of Literature.

Authors:  Yin-Shuo Chang; Chang-Cheng Chang; Jen-Hsiang Shen; Yu-Tsung Chen; Karen Kar-Wun Chan
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817
View more
  10 in total

Review 1.  [New botulinum toxins for aesthetic dermatology : A comprehensive review].

Authors:  A Patil; M Kassir; U Wollina; M Goldust
Journal:  Hautarzt       Date:  2021-04-06       Impact factor: 0.751

Review 2.  Onset and Duration of AbobotulinumtoxinA for Aesthetic Use in the Upper face: A Systematic Literature Review.

Authors:  Mark Nestor; Joel L Cohen; Marina Landau; Said Hilton; Andreas Nikolis; Syed Haq; Maurizio Viel; Bill Andriopoulos; Inna Prygova; Keith Foster; Alessio Redaelli; Philippe Picaut
Journal:  J Clin Aesthet Dermatol       Date:  2020-12-01

3.  Emerging Trends in Botulinum Neurotoxin A Resistance: An International Multidisciplinary Review and Consensus.

Authors:  Wilson W S Ho; Philipp Albrecht; Pacifico E Calderon; Niamh Corduff; David Loh; Michael U Martin; Je-Young Park; Lis S Suseno; Fang-Wen Tseng; Vasanop Vachiramon; Rungsima Wanitphakdeedecha; Chong-Hyun Won; Jonathan N T Yu; Mary Dingley
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-06-20

Review 4.  Keloids: a review of therapeutic management.

Authors:  Samuel F Ekstein; Saranya P Wyles; Steven L Moran; Alexander Meves
Journal:  Int J Dermatol       Date:  2020-09-09       Impact factor: 3.204

5.  Assessment of Subject and Physician Satisfaction after Long-Term Treatment of Glabellar Lines with AbobotulinumtoxinA (Dysport®/Azzalure®): Primary Results of the APPEAL Noninterventional Study.

Authors:  Elena Gubanova; May Haddad Tabet; Yvonne Bergerova; Olena Moiseieva; Andrey Chemeris; Elena Sanches; Alisa Sharova; Luisa Rodriguez Pose; Romain Raymond; Inna Prygova; Ian Carlisle
Journal:  Aesthetic Plast Surg       Date:  2018-08-17       Impact factor: 2.326

6.  Botulinum toxin-A injection into the anterior belly of the digastric muscle for the prevention of post-operative open bite in class II malocclusions: a case report and literature review.

Authors:  Yei-Jin Kang; Bong Kuen Cha; Dong Soon Choi; In San Jang; Seong-Gon Kim
Journal:  Maxillofac Plast Reconstr Surg       Date:  2019-04-26

Review 7.  Immunogenicity of Botulinum Toxin Formulations: Potential Therapeutic Implications.

Authors:  Warner W Carr; Neal Jain; J Wesley Sublett
Journal:  Adv Ther       Date:  2021-09-13       Impact factor: 3.845

Review 8.  Introduction to the Supplement: A Review of AbobotulinumtoxinA (Dysport).

Authors:  Jeffrey S Dover
Journal:  Aesthet Surg J       Date:  2017-05-01       Impact factor: 4.283

9.  A Comparative In Vivo Study on Three Treatment Approaches to Applying Topical Botulinum Toxin A for Crow's Feet.

Authors:  Yan Cao; Jian-Ping Yang; Xiao-Gang Zhu; Jie Zhu; Hong-Qin Chang; Sheng-Hua Guo; Dan Luo; Bing-Rong Zhou
Journal:  Biomed Res Int       Date:  2018-07-03       Impact factor: 3.411

10.  Long-term Efficacy and Safety of Liquid AbobotulinumtoxinA Formulation for Moderate-to-Severe Glabellar Lines: A Phase III, Double-Blind, Randomized, Placebo-Controlled and Open-Label Study.

Authors:  Philippe Kestemont; Said Hilton; Bill Andriopoulos; Inna Prygova; Catherine Thompson; Magali Volteau; Benjamin Ascher
Journal:  Aesthet Surg J       Date:  2022-02-15       Impact factor: 4.283
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.